The key reason why Opiant Pharmaceuticals (NASDAQ: OPNT) share rocketed in the pre-market session
Opiant Pharmaceuticals (NASDAQ: OPNT) stock surged 13.93% to $9.65 in the pre-market trading after the company reported that the Biomedical Applied Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response in the United States, has an additional contribution of up to $3.5 million. To advance OPNT003, nasal nalmefene, […]
